New Partnership Intends to Advance Hyperhidrosis Research, Treatments, and Support

When it comes to advancing treatments and research, collaboration is key. A new partnership recently formed; this collaborative effort underscores the need for additional support and resources for people living with hyperhidrosis. 

A Brief Overview of Hyperhidrosis

Hyperhidrosis is a condition characterized by excessive sweating that isn’t caused by stress or anxiety, heat, or exercise. In its primary form, hyperhidrosis occurs due to overactive nerve signaling to the sweat glands. The secondary form causes excessive sweating due to a medical condition such as diabetes, thyroid issues, or nervous system disorders. Regardless, people with hyperhidrosis experience heavy sweating that may soak through clothes, increase the risk of infections, or cause social anxiety or feelings of shame. The sweatiness most often occurs on the face, feet, hands, or underarms. 

Current hyperhidrosis treatments include nerve-blockers, Botox injections, prescription creams and antiperspirants, nerve surgery, sweat gland removal, or antidepressants (which can reduce sweating). The miraDry system, which offers non-invasive treatment, also offers an innovative therapeutic method. miraDry uses thermal energy to eliminate sweat glands and reduce sweating and odor. 

Partnering to Shift and Improve Care

miraDry, in a June 2023 news release, shared that it had partnered with the International Hyperhidrosis Society, the world’s only nonprofit organization dedicated to improving the lives of people affected by hyperhidrosis. The International Hyperhidrosis Society promotes research in this sphere, aims to educate healthcare providers, advocates for treatments and care accessibility, and raises awareness of the social, emotional, and physical impacts of this condition. 

Through this unique partnership, miraDry and the International Hyperhidrosis Society will blend together their expertise to develop a stronger global awareness of hyperhidrosis. The partnership seeks to develop comprehensive training programs and educational tools for providers, while also reaffirming the companies’ commitments to the community.

Learn more about this condition and the life impacts it can have through our interview with Dr. David Pariser, the founding president and board member of the International Hyperhidrosis Society.

Jessica Lynn

Jessica Lynn

Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

Share this post

Follow us